Cargando…

Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents

BACKGROUND & AIM: There is currently no agreement on the screening strategy for non-alcoholic fatty liver disease (NAFLD) in children at risk. The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) recommends screening for NAFLD using alanine aminotransfer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ezaizi, Yamen, Kabbany, Mohammad Nasser, Conjeevaram Selvakumar, Praveen Kumar, Sarmini, Muhammed Talal, Singh, Amandeep, Lopez, Rocio, Nobili, Valerio, Alkhouri, Naim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001548/ https://www.ncbi.nlm.nih.gov/pubmed/32039376 http://dx.doi.org/10.1016/j.jhepr.2019.06.005

Ejemplares similares

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
por: Asfari, Mohammad Maysara, et al.
Publicado: (2020)

Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD)
por: Alkhouri, Naim, et al.
Publicado: (2014)

Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease
por: Tabbaa, Adam, et al.
Publicado: (2015)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019)

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database
por: Alkhouri, Naim, et al.
Publicado: (2022)

Hereditary Hemorrhagic Telangiectasia With Liver Vascular Malformation Presenting With High-Output Heart Failure
por: Singh, Gurshawn, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
por: Khandelwal, Reshu, et al.
Publicado: (2021)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes
por: Alkhouri, Naim, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?
por: Tomah, Shaheen, et al.
Publicado: (2020)

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
por: Castillo-Leon, Eduardo, et al.
Publicado: (2022)

The association between perceived stress, acculturation, and non-alcoholic fatty liver disease in Mexican-origin adults in Southern Arizona
por: Maldonado, Adriana, et al.
Publicado: (2023)

Segmental Arterial Mediolysis Presenting as a Pancreatic Mass in a Pediatric Patient: A Case Report
por: Bhesania, Natalie, et al.
Publicado: (2023)

Is Non-Alcoholic Fatty Liver Disease Less Frequent among Women with Prader-Willi Syndrome?
por: Bedogni, Giorgio, et al.
Publicado: (2014)

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
por: Giorgio, Valentina, et al.
Publicado: (2013)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Tomah, Shaheen, et al.
Publicado: (2021)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

Gallbladder Adenomyomatosis in an Infant
por: Chen, Charles B., et al.
Publicado: (2020)

Non-alcoholic fatty liver disease: A patient guideline
por: Francque, Sven M., et al.
Publicado: (2021)

Paediatric Non-Alcoholic Fatty Liver Disease: Impact on Patients and Mothers’ Quality of Life
por: Mazzone, Luigi, et al.
Publicado: (2013)

Measurement of Quality-of-Life Outcomes in Pediatric and Young Adult Patients Treated for Eosinophilic Esophagitis
por: Chen, Charles B, et al.
Publicado: (2022)

Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease
por: Rossi, Francesca, et al.
Publicado: (2012)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
por: Alisi, Anna, et al.
Publicado: (2011)

Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
por: Nobili, Valerio, et al.
Publicado: (2016)

ERCP and EUS technique in situs inversus totalis: preparing for a left-sided plot twist
por: Naser, Jason, et al.
Publicado: (2022)

What are parents doing to reduce adolescent alcohol misuse? Evaluating concordance with parenting guidelines for adolescent alcohol use
por: Yap, Marie B H, et al.
Publicado: (2015)

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
por: Zhu, Jin-Zhou, et al.
Publicado: (2016)

Simple diagnostic algorithm identifying at-risk nonalcoholic fatty liver disease patients needing specialty referral within the United States
por: Alkhouri, Naim, et al.
Publicado: (2022)

The Protein-Sparing Modified Fast Diet: An Effective and Safe Approach to Induce Rapid Weight Loss in Severely Obese Adolescents
por: Bakhach, Marwan, et al.
Publicado: (2016)

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment
por: Alkhouri, Naim, et al.
Publicado: (2019)

Metabolic profiling of adolescent non-alcoholic fatty liver disease
por: Hartley, April, et al.
Publicado: (2019)

Non-alcoholic Fatty Liver in Children and Adolescents in Saudi Arabia
por: Mujlli, Gadah, et al.
Publicado: (2023)

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis
por: Davison, Beth A, et al.
Publicado: (2021)

A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications
por: Rieder, Florian, et al.
Publicado: (2016)

Does Vitamin E Improve the Outcomes of Pediatric Nonalcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis
por: Sarkhy, Ahmed A., et al.
Publicado: (2014)

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints
por: Alkhouri, Naim, et al.
Publicado: (2019)

A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
por: Young, Erin Nicole, et al.
Publicado: (2022)

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
por: Harrison, Stephen A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0ffb3kd89s36fksqj1p1t7hrl